[The economic evaluation of vaccination against infectious cough in horses using the cost-benefit analysis].
Approximately 40% of all horses in the Federal Republic of Germany had infectious respiratory disease in 1982. Although an expert vaccine prophylaxis confers a reliable protection, conventional therapy is preferred over vaccination because of the cost. The cost/effect analysis carried out in this investigation demonstrates that vaccination should be favoured also for economic reasons. Based on the individual animal immune prophylaxis saves the horse owner at least 415 DM per year. This analysis did not take into account the danger of a transmission to man and related infection chains of viruses primarily responsible for respiratory disease in horses.